Showing results (91-100 of 143) with videos related to
Sort By:
Pageof 15
European Journal of Pharmacology|June 11, 1993
NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonistsN A Moore, A Blackman, S Awere, et al.Journal of Pharmaceutical Sciences|May 1, 1994
Anticonvulsant properties of N-substituted alpha,alpha-diamino acid derivativesH Kohn, K N Sawhney, D W Robertson, et al.Journal of Medicinal Chemistry|May 1, 1987
Imidazole anticonvulsants: structure-activity relationships of [(biphenylyloxy)alkyl]imidazolesD W Robertson, E E Beedle, R Lawson, et al.Journal of the Experimental Analysis of Behavior|March 1, 1972
Schedule control of the vocal behavior of Cebus monkeysJ D Leander, M A Milan, K B Jasper, et al.Brain Research|May 10, 1988
N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugsJ D Leander, R R Lawson, P L Ornstein, et al.The Journal of Pharmacology and Experimental Therapeutics|April 1, 1990
Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker ratW N Shaw, C H Mitch, J D Leander, et al.Journal of Neural Transmission. General Section|January 1, 1991
Neuroprotectant effects of LY274614, a structurally novel systemically active competitive NMDA receptor antagonistD D Schoepp, P L Ornstein, C R Salhoff, et al.Epilepsia|November 1, 1988
Pharmacology of LY201409, a potent benzamide anticonvulsantD W Robertson, R R Lawson, R C Rathbun, et al.Journal of Medicinal Chemistry|July 1, 1988
Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitorD W Robertson, J H Krushinski, R W Fuller, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligandsD M Zimmerman, J D Leander, J K Reel, et al.Pageof 15